These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35283189)

  • 1. Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death.
    Yang R; Sun L; Li CF; Wang YH; Xia W; Liu B; Chu YY; Bover L; Vien L; Hung MC
    J Biol Chem; 2022 Apr; 298(4):101821. PubMed ID: 35283189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-9 blockade synergizes with ATM inhibition to induce potent anti-tumor immunity.
    Zheng S; Song J; Linghu D; Yang R; Liu B; Xue Z; Chen Q; Liu C; Zhong D; Hung MC; Sun L
    Int J Biol Sci; 2023; 19(3):981-993. PubMed ID: 36778120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progress on T-cell immunoglobulin mucin 3/galectin 9 (TIM-3/galectin-9) in tumour immunity].
    Ma L; Bai L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Aug; 40(8):754-760. PubMed ID: 39215674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes.
    Kanzaki M; Wada J; Sugiyama K; Nakatsuka A; Teshigawara S; Murakami K; Inoue K; Terami T; Katayama A; Eguchi J; Akiba H; Yagita H; Makino H
    Endocrinology; 2012 Feb; 153(2):612-20. PubMed ID: 22186414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities.
    Pérez Sáez JM; Hockl PF; Cagnoni AJ; Méndez Huergo SP; García PA; Gatto SG; Cerliani JP; Croci DO; Rabinovich GA
    Angiogenesis; 2021 Feb; 24(1):1-5. PubMed ID: 33006019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of neutralizing antibodies reacting with the 213-224 amino-acid segment of human galectin-9.
    Lhuillier C; Barjon C; Baloche V; Niki T; Gelin A; Mustapha R; Claër L; Hoos S; Chiba Y; Ueno M; Hirashima M; Wei M; Morales O; Raynal B; Delhem N; Dellis O; Busson P
    PLoS One; 2018; 13(9):e0202512. PubMed ID: 30204750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.
    Zhou K; Guo S; Tong S; Sun Q; Li F; Zhang X; Qiao Y; Liang G
    Stem Cells Dev; 2018 Sep; 27(17):1191-1202. PubMed ID: 29978730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Galectin-9 Treatment on the Phenotype and Function of NK-92MI Cells in the Presence of Different Serum Supplements.
    Meggyes M; Nagy DU; Balassa T; Godony K; Peterfalvi A; Szereday L; Polgar B
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oridonin Could Inhibit Inflammation and T-cell Immunoglobulin and Mucin-3/Galectin-9 (TIM-3/Gal-9) Autocrine Loop in the Acute Myeloid Leukemia Cell Line (U937) as Compared to Doxorubicin.
    Nasri F; Sadeghi F; Behranvand N; Samei A; Bolouri MR; Azari T; Abdollahi E; Ghazizadeh F; Motevalian M; Hassan ZM; Falak R
    Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):602-611. PubMed ID: 33463129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of T-cell immunoglobulin mucin-3 and its ligand galectin-9 in antitumor immunity and cancer immunotherapy.
    Yang R; Hung MC
    Sci China Life Sci; 2017 Oct; 60(10):1058-1064. PubMed ID: 29027155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIM-3 does not act as a receptor for galectin-9.
    Leitner J; Rieger A; Pickl WF; Zlabinger G; Grabmeier-Pfistershammer K; Steinberger P
    PLoS Pathog; 2013 Mar; 9(3):e1003253. PubMed ID: 23555261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors.
    Komita H; Koido S; Hayashi K; Kan S; Ito M; Kamata Y; Suzuki M; Homma S
    Oncol Rep; 2015 Oct; 34(4):2099-105. PubMed ID: 26239720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of M6903, an antagonistic anti-TIM-3 monoclonal antibody.
    Zhang D; Jiang F; Zaynagetdinov R; Huang H; Sood VD; Wang H; Zhao X; Jenkins MH; Ji Q; Wang Y; Nannemann DP; Musil D; Wesolowski J; Paoletti A; Bartholomew T; Derner MG; An Q; Iffland C; Halle JP
    Oncoimmunology; 2020; 9(1):1744921. PubMed ID: 32313722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity.
    Li Y; Feng J; Geng S; Geng S; Wei H; Chen G; Li X; Wang L; Wang R; Peng H; Han G; Shen B; Li Y
    Mol Immunol; 2011 Jan; 48(4):670-7. PubMed ID: 21146220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy.
    Lau LS; Mohammed NBB; Dimitroff CJ
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of galectin-9 mediated responses in monocytes and T-cells by pregnancy-specific glycoprotein 1.
    Mendoza M; Ballesteros A; Rendon-Correa E; Tonk R; Warren J; Snow AL; Stowell SR; Blois SM; Dveksler G
    J Biol Chem; 2024 Sep; 300(9):107638. PubMed ID: 39121996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.
    Shimmura-Tomita M; Wang M; Taniguchi H; Akiba H; Yagita H; Hori J
    PLoS One; 2013; 8(5):e63620. PubMed ID: 23667648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-9-based immune risk score model helps to predict relapse in stage I-III small cell lung cancer.
    Chen P; Zhang L; Zhang W; Sun C; Wu C; He Y; Zhou C
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33082168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.
    Steelman AJ; Smith R; Welsh CJ; Li J
    J Biol Chem; 2013 Aug; 288(33):23776-87. PubMed ID: 23836896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of full-length Toxascaris leonina galectin with two carbohydrate-recognition domains.
    Jeong MS; Hwang HG; Yu HS; Jang SB
    Acta Crystallogr D Biol Crystallogr; 2013 Feb; 69(Pt 2):168-75. PubMed ID: 23385453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.